oncotomskСибирский онкологический журналSiberian journal of oncology1814-48612312-3168Tomsk National Research Medical Сепtеr of the Russian Academy of Sciencesoncotomsk-113Research ArticleОБЗОРЫREVIEWSЛУЧЕВАЯ ТЕРАПИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ С УЧЕТОМ ФАКТОРОВ ПРОГНОЗАRADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORSСимоновК. А.SimonovK. A.simonov_ka@bk.ruСтарцеваЖ. А.StartsevaZh. A.simonov_ka@bk.ruСлонимскаяЕ. М.SlonimskayaE. M.simonov_ka@bk.ruТомский НИИ онкологии; Национальный исследовательский Томский политехнический университетРоссияTomsk Cancer Research Institute; National Research Tomsk Polytechnic UniversityRussian FederationТомский НИИ онкологии; Сибирский государственный медицинский университет, ТомскРоссияTomsk Cancer Research Institute; Siberian State Medical University, TomskRussian Federation201516022016117683Copyright © Симонов К.А., Старцева Ж.А., Слонимская Е.М., 20162016Симонов К.А., Старцева Ж.А., Слонимская Е.М.Simonov K.A., Startseva Z.A., Slonimskaya E.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.siboncoj.ru/jour/article/view/113

Обзор посвящен применению послеоперационной лучевой терапии у больных раком молочной железы после выполнения радикальной мастэктомии. Подчеркивается необходимость дифференцированного подхода к лучевой терапии, который должен базироваться на оценке клинико-морфологических факторов, определяющих риск развития локо-регионарного рецидива РМЖ.

This review about the application of radiotherapy in breast cancer patients after radical mastectomy. Emphasizes the need for a differentiated approach to radiation therapy, which should be based on the definition of clinical morphological factors that determine the risk of loco-regional recurrence of breast cancer.

рак молочной железырадикальная мастэктомиярецидивадъювантная лучевая терапияфакторы прогнозаbreast cancerradical mastectomylocoregional recurrenceadjuvant radiation therapyprognostic factorsReferencesЕфимкина Ю.В., Гладилина И.А., Шабанов М.А. Сравнительный анализ отдаленных результатов лечения больных раком молочной железы I–IIA стадий в зависимости от основных прогностических факторов // Опухоли женской репродуктивной системы. 2010. № 4. С. 6–9.Efimkina Yu.V., Gladilina I.A., Shabanov M.A. Comparative analysis of the long-term results of treatment of patients with breast cancer stages I–IIA according to the main prognostic factors // Opukholi zhenskoy reproduktivnoy sistemy. 2010. № 4. P. 6–9. [in Russian]Жогина Ж.А., Мусабаева Л.И., Слонимская Е.М. Показания к выбору объема адъювантной лучевой терапии при радикальной ма стэктомии у больных раком молочной // Сибирский онкологический журнал. 2005. № 3. С. 3–10.Zhogina Zh.A., Musabaeva L.I., Slonimskaya E.M. Indications for the choice of adjuvant radiotherapy extent for patients breast cancer after radical mastectomy // Sibirskiy onkologicheskiy zhurnal. 2005. № 3. P. 3–10. [in Russian]Симонов К.А., Старцева Ж.А., Слонимская Е.М. Отдаленные результаты комплексного лечения больных раком молочной железы с использованием различного объема адъювантной лучевой терапии // Сибирский онкологический журнал. 2013. № 2. С. 30–35.Simonov K.A., Startseva Zh.A., Slonimskaya E.M. Long-term outcomes in breast cancer patients after complex treatment with adjuvant radiation therapy // Sibirskiy onkologicheskiy zhurnal. 2013. Vol. 56 (2). P. 30–35. [in Russian]Симонов К.А., Старцева Ж.А., Слонимская Е.М. Роль адъю вантной лучевой терапии в комплексном лечении больных раком молочной железы // Бюллетень Сибирского отделения Российской академии медицинских наук. 2012. Т. 32, № 6. С. 34–40.Simonov K.A., Startseva Zh.A., Slonimskaya E.M. Role of postoperative radiotherapy in the treatment of breast cancer patients // Bjulleten’ Sibirskogo otdelenija Rossijskoj akademii medicinskih nauk. 2012. Vol. 32 (6). P. 34–40. [in Russian]Старцева Ж.А., Великая В.В., Симонов К.А., Мусабаева Л.И. Послеоперационная лучевая терапия как метод профилактики мест ных рецидивов рака молочной железы // Радиация и риск. 2013. Т. 22, № 3. С. 72–79.Startseva Zh.A., Velikaya V.V., Simonov K.A., Musabaeva L.I. Postoperative radiation therapy as a method of prevention of local recurrence of breast cancer // Radiatsiya i risk. 2013. T. 22. № 3. P. 72–79. [in Russian]Старцева Ж.А., Симонов К.А., Слонимская Е.М. Дифферен цированный подход к назначению адъювантной лучевой терапии у больных операбельным раком молочной железы // Радиация и риск. 2014. Т. 23, № 2. С. 102–111.Startseva Zh.A., Simonov K.A., Slonimskaya E.M. Differentiated approach to adjuvant radiotherapy in patients with operable breast cancer // Radiatsiya i risk. 2014. T. 23. № 2. P. 102–111. [in Russian]Щепотин И.Б., Зотов А.С., Зайчук В.В. Факторы риска развития местных рецидивов инвазивного рака молочной железы // Онкология. 2010. Т. 4, № 12. С. 347–350.Shchepotin I.B., Zotov A.S., Zaychuk V.V. Risk factors for local recurrence of invasive breast cancer // Onkologiya. 2010. T. 4. № 12. P. 347–350. [in Russian]Abi-Raad R., Boutrus R., Wang R., Niemierko A., Macdonald S., Smith B., Taghian A.G. Patterns and risk factors of locoregional recurrence in T1–T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 81 (3). Р. 151–157. doi: 10.1016/j.ijrobp.2011.01.015.Abi-Raad R., Boutrus R., Wang R., Niemierko A., Macdonald S., Smith B., Taghian A.G. Patterns and risk factors of locoregional recurrence in T1–T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 81 (3). Р. 151–157. doi: 10.1016/j.ijrobp.2011.01.015.Altinyollar H., Berberoрlu U., Irkin F. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer // J. Surg. Oncol. 2007. Vol. 95 (7). Р. 567–571.Altinyollar H., Berberoрlu U., Irkin F. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer // J. Surg. Oncol. 2007. Vol. 95 (7). Р. 567–571.AndersonP., FreedmanG., Nicolaou N., Sharma N., Li T., Topham N., Morrow M. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates? // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 74 (1). P. 81–85. doi: 10.1016/j.ijrobp.2008.06.1940.Anderson P., Freedman G., Nicolaou N., Sharma N., Li T., Topham N., Morrow M. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates? // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 74 (1). P. 81–85. doi: 10.1016/j.ijrobp.2008.06.1940.Bauman L., Barth R.J., Rosenkranz K.M. Breast conservation in women with multifocal-multicentric breast cancer: is it feasible? // Ann. Surg. Oncol. 2010. Suppl. 3. Р. 325–329. doi: 10.1245/s10434-010-1247-1.Bauman L., Barth R.J., Rosenkranz K.M. Breast conservation in women with multifocal-multicentric breast cancer: is it feasible? // Ann. Surg. Oncol. 2010. Suppl. 3. Р. 325–329. doi: 10.1245/s10434-0101247-1.Ceilley E., Jagsi R., Goldberg S., Grignon L., Kachnic L., Powell S., Taghian A. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61. (2). P. 365–367.Ceilley E., Jagsi R., Goldberg S., Grignon L., Kachnic L., Powell S., Taghian A. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61. (2). P. 365–367.Childs S.K., Chen Y.H., Duggan M.M., Golshan M., Pochebit S., Wong J.S., Bellon J.R. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 84 (5). Р. 1133–1138. doi: 10.1016/j.ijrobp.2012.02.048.Childs S.K., Chen Y.H., Duggan M.M., Golshan M., Pochebit S., Wong J.S., Bellon J.R. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 84 (5). Р. 1133–1138. doi: 10.1016/j.ijrobp.2012.02.048.Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., Godwin J., Gray R., Hicks C., James S., MacKinnon E., McGale P., McHugh T., Peto R., Taylor C., Wang Y. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials // Lancet. 2005. Vol. 366 (9503). Р. 2087–2106.Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., Godwin J., Gray R., Hicks C., James S., MacKinnon E., McGale P., McHugh T., Peto R., Taylor C., Wang Y. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials // Lancet. 2005. Vol. 366 (9503). Р. 2087–2106.Dragun A.E., Huang B., Gupta S., Crew J.B., Tucker T.C. One Decade Later: Trends and Disparities in the Application of Post-Mastectomy Radiotherapy Since the Release of the American Society of Clinical Oncology Clinical Practice Guidelines // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (5). e. 591–596. doi: 10.1016/j.ijrobp.2012.02.002.Dragun A.E., Huang B., Gupta S., Crew J.B., Tucker T.C. One Decade Later: Trends and Disparities in the Application of Post-Mastectomy Radiotherapy Since the Release of the American Society of Clinical Oncology Clinical Practice Guidelines // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (5). e. 591–596. doi: 10.1016/j.ijrobp.2012.02.002.Duraker N., Demi D., Bati B., Yilmaz B.D., Bati Y., Çaynak Z.C., Sobutay E. Survival Benefit of Post-mastectomy Radiotherapy in Breast Carcinoma Patients with T1-2 Tumor and 1–3 Axillary Lymph Node(s) Metastasis // Jpn. J. Clin. Oncol. 2012. Vol. 42 (7). Р. 601–608. doi: 10.1093/jjco/hys052.Duraker N., Demi D., Bati B., Yilmaz B.D., Bati Y., Çaynak Z.C., Sobutay E. Survival Benefit of Post-mastectomy Radiotherapy in Breast Carcinoma Patients with T1-2 Tumor and 1–3 Axillary Lymph Node(s) Metastasis // Jpn. J. Clin. Oncol. 2012. Vol. 42 (7). Р. 601–608. doi: 10.1093/jjco/hys052.Floyd S.R., Taghian A.G. Post-mastectomy radiation in large nodenegative breast tumors: does size really matter? // Radiother Oncol. 2009. Vol. 91 (1). Р. 33–37. doi: 10.1016/j.radonc.2008.09.015.Floyd S.R., Taghian A.G. Post-mastectomy radiation in large nodenegative breast tumors: does size really matter? // Radiother Oncol. 2009. Vol. 91 (1). Р. 33–37. doi: 10.1016/j.radonc.2008.09.015.Fodor J., Polgar C., Major T., Németh G. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size // Strahlenther Onkol. 2003. Vol. 179 (3). Р. 197–202.Fodor J., Polgar C., Major T., Németh G. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size // Strahlenther Onkol. 2003. Vol. 179 (3). Р. 197–202.Fortin A., Dagnault A., Blondeau L., Vu T.T., Larochelle M. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breastconserving surgery with or without regional irradiation // Int. J. Radiat. Oncol. Biol. Phys. 2006. Vol. 65 (1). Р. 33–39.Fortin A., Dagnault A., Blondeau L., Vu T.T., Larochelle M. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breastconserving surgery with or without regional irradiation // Int. J. Radiat. Oncol. Biol. Phys. 2006. Vol. 65 (1). Р. 33–39.Garg A.K., Strom E.A., McNeese M.D., Buzdar A.U., Hortobagyi G.N., Kuerer H.M., Perkins G.H., Singletary S.E., Hunt K.K., Sahin A., Schechter N., Valero V., Tucker S.L., Buchholz T.A. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2004. 59 (1). P. 138–145.Garg A.K., Strom E.A., McNeese M.D., Buzdar A.U., Hortobagyi G.N., Kuerer H.M., Perkins G.H., Singletary S.E., Hunt K.K., Sahin A., Schechter N., Valero V., Tucker S.L., Buchholz T.A. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2004. 59 (1). P. 138–145.Goldhirsch A., Ingle J.N., Gelber R.D., Coates A.S., Thürlimann B., Senn H.J. Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer // Ann. Oncol. 2009. Vol. 20. Р. 1319–1329. doi: 10.1093/annonc/mdp322.Goldhirsch A., Ingle J.N., Gelber R.D., Coates A.S., Thürlimann B., Senn H.J. Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer // Ann. Oncol. 2009. Vol. 20. Р. 1319–1329. doi: 10.1093/annonc/mdp322.Hamamoto Y., Ohsumi Sh., Aogi K., Shinohara S., Nakajima N., Kataoka M., Takashima S. Impact of aggregate of risk factors for isolated locoregional failure in breast cancer patients treated with mastectomy without radiotherapy // Breast Cancer. 2013. Vol. 20 (3). Р. 247–253. doi: 10.1007/s12282-012-0335-4.Hamamoto Y., Ohsumi Sh., Aogi K., Shinohara S., Nakajima N., Kataoka M., Takashima S. Impact of aggregate of risk factors for isolated locoregional failure in breast cancer patients treated with mastectomy without radiotherapy // Breast Cancer. 2013. Vol. 20 (3). Р. 247–253. doi: 10.1007/s12282-012-0335-4.Hastings J., Iganej S., Huang C., Huang R., Slezak J. Risk Factors for Locoregional Recurrence After Mastectomy in Stage T1N0 Breast Cancer // Am. J. Clin. Oncol. 2014. Vol. 37 (5). P. 486–491. doi: 10.1097/COC.0b013e31827e54c2.Hastings J., Iganej S., Huang C., Huang R., Slezak J. Risk Factors for Locoregional Recurrence After Mastectomy in Stage T1N0 Breast Cancer // Am. J. Clin. Oncol. 2014. Vol. 37 (5). P. 486–491. doi: 10.1097/COC.0b013e31827e54c2.Jagsi R., Raad R.A., Goldberg S., Sullivan T., Michaelson J., Powell S.N., Taghian A.G. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 62 (4). P. 1035–1039.Jagsi R., Raad R.A., Goldberg S., Sullivan T., Michaelson J., Powell S.N., Taghian A.G. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 62 (4). P. 1035–1039.Kubicky C., Mongoue-Tchokote S. Prognostic Significance of the Number of Positive Lymph Nodes in Women With T1-2N1 Breast Cancer Treated With Mastectomy: Should Patients With 1, 2, and 3 Positive Lymph Nodes Be Grouped Together? // Int. J. Radiat. Oncol. Biol. Phys. 2013. Vol. 85 (5). P. 1200–1205. doi: 10.1016/j.ijrobp.2012.11.005.Kubicky C., Mongoue-Tchokote S. Prognostic Significance of the Number of Positive Lymph Nodes in Women With T1-2N1 Breast Cancer Treated With Mastectomy: Should Patients With 1, 2, and 3 Positive Lymph Nodes Be Grouped Together? // Int. J. Radiat. Oncol. Biol. Phys. 2013. Vol. 85 (5). P. 1200–1205. doi: 10.1016/j.ijrobp.2012.11.005.Kunkler I.H., Canney P., van Tienhoven G., Russell N.S. Elucidating the role of chest wall irradiation in ‘intermediate-risk’ breast cancer: The MRC/EORTC SUPREMO trial // Clin. Oncol. (R Coll Radiol). 2008. Vol. 20 (1). Р. 31–34.Kunkler I.H., Canney P., van Tienhoven G., Russell N.S. Elucidating the role of chest wall irradiation in ‘intermediate-risk’ breast cancer: The MRC/EORTC SUPREMO trial // Clin. Oncol. (R. Coll. Radiol.). 2008. Vol. 20 (1). Р. 31–34.Kyndi M., Srensen F.B., Knudsen H., Overgaard M., Nielsen H.M., Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group // J. Clin. Oncol. 2008. Vol. 26 (9). Р. 1419–1426. doi: 10.1200/JCO.2007.14.5565.Kyndi M., Srensen F.B., Knudsen H., Overgaard M., Nielsen H.M., Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group // J. Clin. Oncol. 2008. Vol. 26 (9). Р. 1419–1426. doi: 10.1200/JCO.2007.14.5565.Lee J.C., Truong P.T., Kader H.A., Speers C.H., Olivotto I.A. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer // Clin. Oncol. 2005. Vol. 17. (8). P. 623–629.Lee J.C., Truong P.T., Kader H.A., Speers C.H., Olivotto I.A. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer // Clin. Oncol. 2005. Vol. 17. (8). P. 623–629.Livi L., Meattini I., Di Cataldo V., Cardillo Cde L., Scotti V., Sanchez L., Nori J., Agresti B., Iermano C., Pasquetti E.M., Bianchi S., Cataliotti L., Biti G. Postmastectomy radiotherapy in breast cancer adjuvant treatment // Minerva Chir. 2010. Vol. 65 (5). P. 527–536.Livi L., Meattini I., Di Cataldo V., Cardillo Cde L., Scotti V., Sanchez L., Nori J., Agresti B., Iermano C., Pasquetti E.M., Bianchi S., Cataliotti L., Biti G. Postmastectomy radiotherapy in breast cancer adjuvant treatment // Minerva Chir. 2010. Vol. 65 (5). P. 527–536.Martinez-Ramos D., Escrig J., Torrella A., Hoashi J.S., Alcalde M., Salvador J.L. Risk of recurrence of non-metastatic breast cancer in women under 40 years: a population registry cancer study in a European country // Breast J. 2012. Vol. 18. (2). Р. 118–123. doi: 10.1111/j.15244741.2011.01208.x.Martinez-Ramos D., Escrig J., Torrella A., Hoashi J.S., Alcalde M., Salvador J.L. Risk of recurrence of non-metastatic breast cancer in women under 40 years: a population registry cancer study in a European country // Breast J. 2012. Vol. 18. (2). Р. 118–123. doi: 10.1111/j.15244741.2011.01208.x.Matsunuma R., Oguchi M., Fujikane T., Matsuura M., Sakai T., Kimura K., Morizono H., Iijima K., Izumori A., Miyagi Y., Nishimura S., Makita M., Gomi N., Horii R., Akiyama F., Iwase T. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (3). Р. 845–852. doi: 10.1016/j.ijrobp.2011.08.029.Martinez-Ramos D., Escrig J., Torrella A., Hoashi J.S., Alcalde M., Salvador J.L. Risk of recurrence of non-metastatic breast cancer in women under 40 years: a population registry cancer study in a European country // Breast J. 2012. Vol. 18. (2). Р. 118–123. doi: 10.1111/j.15244741.2011.01208.x.Miles R.C., Gullerud R.E., Lohse C.M., Jakub J.W., Degnim A.C., Boughey J.C. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age // Ann. Surg. Oncol. 2012. Vol. 19 (4). Р. 1153–1159. doi: 10.1245/s10434-011-2084-6.Matsunuma R., Oguchi M., Fujikane T., Matsuura M., Sakai T., Kimura K., Morizono H., Iijima K., Izumori A., Miyagi Y., Nishimura S., Makita M., Gomi N., Horii R., Akiyama F., Iwase T. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (3). Р. 845–852. doi: 10.1016/j.ijrobp.2011.08.029.Moo T. A., McMillan R., Lее M., Stempel M., Patil S., Ho A., ElTamer M. Selection Criteria for Postmastectomy Radiotherapy in T1–T2 Tumors with 1 to 3 Positive Lymph Nodes // Ann. Surg. Oncol. 2013. Vol. 20 (10). Р. 3169–3174. doi: 10.1245/s10434-013-3117-0.Matsunuma R., Oguchi M., Fujikane T., Matsuura M., Sakai T., Kimura K., Morizono H., Iijima K., Izumori A., Miyagi Y., Nishimura S., Makita M., Gomi N., Horii R., Akiyama F., Iwase T. Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (3). Р. 845–852. doi: 10.1016/j.ijrobp.2011.08.029.Munshi A., Prabhu A., Kunkler I. Post mastectomy radiotherapy in one to three lymph node positive breast cancer // Acta Oncol. 2012. Vol. 51 (4). Р. 547–550. doi: 10.3109/0284186X.2011.633929.Miles R.C., Gullerud R.E., Lohse C.M., Jakub J.W., Degnim A.C., Boughey J.C. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age // Ann. Surg. Oncol. 2012. Vol. 19 (4). Р. 1153–1159. doi: 10.1245/s10434-011-2084-6.Nagao Т., Kinoshita Т., Tamura N., Hojo T., Morota M., Kagami Y. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy // Int. J. Clin. Oncol. 2013. Vol. 18 (1). Р. 54–61. doi: 10.1007/s10147-0110343-y.Miles R.C., Gullerud R.E., Lohse C.M., Jakub J.W., Degnim A.C., Boughey J.C. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age // Ann. Surg. Oncol. 2012. Vol. 19 (4). Р. 1153–1159. doi: 10.1245/s10434-011-2084-6.Nixon A., Neuberg D., Hayes D., Gelman R., Connolly J.L., Schnitt S., Abner A., Recht A., Vicini F., Harris J.R. Relationship of patients age to pathologic features of the tumor and prognosis for patients with stage 1 or 11 breast cancer // J. Clin. Oncol. 1994. Vol. 12. Р. 888–894.Moo T. A., McMillan R., Lее M., Stempel M., Patil S., Ho A., ElTamer M. Selection Criteria for Postmastectomy Radiotherapy in T1–T2 Tumors with 1 to 3 Positive Lymph Nodes // Ann. Surg. Oncol. 2013. Vol. 20 (10). Р. 3169–3174. doi: 10.1245/s10434-013-3117-0.Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials // Radiother. Oncol. 2007. Vol. 82 (3). P. 247−253.Moo T. A., McMillan R., Lее M., Stempel M., Patil S., Ho A., ElTamer M. Selection Criteria for Postmastectomy Radiotherapy in T1–T2 Tumors with 1 to 3 Positive Lymph Nodes // Ann. Surg. Oncol. 2013. Vol. 20 (10). Р. 3169–3174. doi: 10.1245/s10434-013-3117-0.Panoff J.E., Hurley J., Takita C., Reis I.M., Zhao W., Sujoy V., Gomez C.R., Jorda M., Koniaris L., Wright J.L. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation // Breast Cancer Res. Treat. 2011. Vol. 128 (3). Р. 899–906. doi: 10.1007/s10549-011-1495-1.Munshi A., Prabhu A., Kunkler I. Post mastectomy radiotherapy in one to three lymph node positive breast cancer // Acta Oncol. 2012. Vol. 51 (4). Р. 547–550. doi: 10.3109/0284186X.2011.633929.Patani N., Carpenter R. Oncological and aesthetic considerations of conservational surgery for multifocal/multicentric breast cancer // Breast J. 2010. Vol. 16 (3). Р. 222–232. doi: 10.1111/j.1524-4741.2010.00917.x.Munshi A., Prabhu A., Kunkler I. Post mastectomy radiotherapy in one to three lymph node positive breast cancer // Acta Oncol. 2012. Vol. 51 (4). Р. 547–550. doi: 10.3109/0284186X.2011.633929.Paul S., Srivastava K., Chaudhuri T., Rathor S. Post-mastectomy radiotherapy for one to three axillary node positive early breast cancer: To radiate or not to radiate? // Clin. Cancer Investig J. 2013. Vol. 2. Р. 14–19.Nagao Т., Kinoshita Т., Tamura N., Hojo T., Morota M., Kagami Y. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy // Int. J. Clin. Oncol. 2013. Vol. 18 (1). Р. 54–61. doi: 10.1007/s10147-0110343-y.Poortmans P. Evidence based radiation oncology: Breast cancer // Radiother. Oncol. 2007. Vol. 84 (1). P. 84–101.Nagao Т., Kinoshita Т., Tamura N., Hojo T., Morota M., Kagami Y. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy // Int. J. Clin. Oncol. 2013. Vol. 18 (1). Р. 54–61. doi: 10.1007/s10147-0110343-y.Raghav K.P., Hernandez-Aya L.F., Lei X., Chavez-Macgregor M., Meric-Bernstam F., Buchholz T.A., Sahin A., Do K.A., Hortobagyi G.N., Gonzalez-Angulo A.M. Impact of Low Estrogen/Progesterone Receptor Expression on Survival Outcomes in Breast Cancers Previously Classified as Triple Negative Breast Cancers // Cancer. 2012. Vol. 118 (6). Р. 1498–1506. doi: 10.1002/cncr.26431.Nixon A., Neuberg D., Hayes D., Gelman R., Connolly J.L., Schnitt S., Abner A., Recht A., Vicini F., Harris J.R. Relationship of patients age to pathologic features of the tumor and prognosis for patients with stage 1 or 11 breast cancer // J. Clin. Oncol. 1994. Vol. 12. Р. 888–894.Recht A., Edge S., Solin L., Robinson D.S., Estabrook A., Fine R.E., Fleming G.F., Formenti S., Hudis C., Kirshner J.J., Krause D.A., Kuske R.R., Langer A.S., Sledge G.W. Jr., Whelan T.J., Pfister D.G. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. Vol. 19 (5). Р. 1539–1569.Nixon A., Neuberg D., Hayes D., Gelman R., Connolly J.L., Schnitt S., Abner A., Recht A., Vicini F., Harris J.R. Relationship of patients age to pathologic features of the tumor and prognosis for patients with stage 1 or 11 breast cancer // J. Clin. Oncol. 1994. Vol. 12. Р. 888–894.Schiffman S.C., McMasters K.M., Scoggins C.R., Martin R.C., Chagpar A.B. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients // J. Am. Coll. Surg. 2011. Vol. 213 (1). Р. 45–52. doi: 10.1016/j.jamcollsurg.2011.04.024.Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials // Radiother. Oncol. 2007. Vol. 82 (3). P. 247−253.Sheikh F., Rebecca А., Pockaj B., Wasif N., McCullough A.E., Casey W., Kreymerman P., Gray R.J. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk? // Ann. Surg. Oncol. 2011. Vol. 18 (4). Р. 952–956. doi: 10.1245/s10434-010-1406-4.Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials // Radiother. Oncol. 2007. Vol. 82 (3). P. 247−253.Sobin L.H., Greene F.L. Multifocal/multicentric breast carcinoma // Cancer. 2004. Vol. 100 (11). Р. 2488–2489.Panoff J.E., Hurley J., Takita C., Reis I.M., Zhao W., Sujoy V., Gomez C.R., Jorda M., Koniaris L., Wright J.L. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation // Breast Cancer Res. Treat. 2011. Vol. 128 (3). Р. 899–906. doi: 10.1007/s10549-011-1495-1.Stranzl H., Ofner P., Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? // Strahlenther. Onkol. 2006. Vol. 182. Р. 583–588.Panoff J.E., Hurley J., Takita C., Reis I.M., Zhao W., Sujoy V., Gomez C.R., Jorda M., Koniaris L., Wright J.L. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation // Breast Cancer Res. Treat. 2011. Vol. 128 (3). Р. 899–906. doi: 10.1007/s10549-011-1495-1.Taylor M.E., Haffty B.G., Rabinovitch R., Arthur D.W., Halberg F.E., Strom E.A., White J.R., Cobleigh M.A., Edge S.B. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncologybreast // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (4). P. 997–1002. doi: 10.1016/j.ijrobp.2008.10.080.Patani N., Carpenter R. Oncological and aesthetic considerations of conservational surgery for multifocal/multicentric breast cancer // Breast J. 2010. Vol. 16 (3). Р. 222–232. doi: 10.1111/j.1524-4741.2010.00917.x.Trovo M., Durofil E., Polesel J., Roncadin M., Perin T., Mileto M., Piccoli E., Quitadamo D., Massarut S., Carbone A., Trovo M.G. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (2). Р. 153–157. doi: 10.1016/j.ijrobp.2011.12.050.Patani N., Carpenter R. Oncological and aesthetic considerations of conservational surgery for multifocal/multicentric breast cancer // Breast J. 2010. Vol. 16 (3). Р. 222–232. doi: 10.1111/j.1524-4741.2010.00917.x.Truong P.T., Olivotto I.A., Kader H.A., Panades M., Speers C.H., Berthelet E. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61 (5). P. 1337–1347.Paul S., Srivastava K., Chaudhuri T., Rathor S. Post-mastectomy radiotherapy for one to three axillary node positive early breast cancer: To radiate or not to radiate? // Clin. Cancer Investig J. 2013. Vol. 2. Р. 14–19.Truong P.T., Woodward W.A., Thames H.D., Ragaz J., Olivotto I.A., Buchholz T.A. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (1). P. 59–65.Paul S., Srivastava K., Chaudhuri T., Rathor S. Post-mastectomy radiotherapy for one to three axillary node positive early breast cancer: To radiate or not to radiate? // Clin. Cancer Investig J. 2013. Vol. 2. Р. 14–19.Ustaalioglu B.O., Bilici A., Kefeli U., Şeker M., Oncel M., Gezen C., Gumus M., Demirelli F. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancerpatients: single center experience // Am. J. Clin. Oncol. 2012. Vol. 35 (6). Р. 580–586. doi: 10.1097/COC.0b013e31822d9cd6.Poortmans P. Evidence based radiation oncology: Breast cancer // Radiother. Oncol. 2007. Vol. 84 (1). P. 84–101.Wallgren A., Bonetti M., Gelber R., Goldhirsch A., CastiglioneGertsch M., Holmberg S.B., Lindtner J., Thürlimann B., Fey M., Werner I.D., Forbes J.F., Price K., Coates A.S., Collins J. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII // J. Clin. Oncol. 2003. Vol. 21 (7). Р. 1205–1213.Poortmans P. Evidence based radiation oncology: Breast cancer // Radiother. Oncol. 2007. Vol. 84 (1). P. 84–101.Yang P.S., Chen C.M., Liu M.C., Jian J.M., Horng C.F., Liu M.J., Yu B.L., Lee M.Y., Chi C.W. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77 (2). Р. 516–522. doi: 10.1016/j.ijrobp.2009.05.016.Raghav K.P., Hernandez-Aya L.F., Lei X., Chavez-Macgregor M., Meric-Bernstam F., Buchholz T.A., Sahin A., Do K.A., Hortobagyi G.N., Gonzalez-Angulo A.M. Impact of Low Estrogen/Progesterone Receptor Expression on Survival Outcomes in Breast Cancers Previously Classified as Triple Negative Breast Cancers // Cancer. 2012. Vol. 118 (6). Р. 1498–1506. doi: 10.1002/cncr.26431.Raghav K.P., Hernandez-Aya L.F., Lei X., Chavez-Macgregor M., Meric-Bernstam F., Buchholz T.A., Sahin A., Do K.A., Hortobagyi G.N., Gonzalez-Angulo A.M. Impact of Low Estrogen/Progesterone Receptor Expression on Survival Outcomes in Breast Cancers Previously Classified as Triple Negative Breast Cancers // Cancer. 2012. Vol. 118 (6). Р. 1498–1506. doi: 10.1002/cncr.26431.Raghav K.P., Hernandez-Aya L.F., Lei X., Chavez-Macgregor M., Meric-Bernstam F., Buchholz T.A., Sahin A., Do K.A., Hortobagyi G.N., Gonzalez-Angulo A.M. Impact of Low Estrogen/Progesterone Receptor Expression on Survival Outcomes in Breast Cancers Previously Classified as Triple Negative Breast Cancers // Cancer. 2012. Vol. 118 (6). Р. 1498–1506. doi: 10.1002/cncr.26431.Recht A., Edge S., Solin L., Robinson D.S., Estabrook A., Fine R.E., Fleming G.F., Formenti S., Hudis C., Kirshner J.J., Krause D.A., Kuske R.R., Langer A.S., Sledge G.W. Jr., Whelan T.J., Pfister D.G. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. Vol. 19 (5). Р. 1539–1569.Recht A., Edge S., Solin L., Robinson D.S., Estabrook A., Fine R.E., Fleming G.F., Formenti S., Hudis C., Kirshner J.J., Krause D.A., Kuske R.R., Langer A.S., Sledge G.W. Jr., Whelan T.J., Pfister D.G. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. Vol. 19 (5). Р. 1539–1569.Recht A., Edge S., Solin L., Robinson D.S., Estabrook A., Fine R.E., Fleming G.F., Formenti S., Hudis C., Kirshner J.J., Krause D.A., Kuske R.R., Langer A.S., Sledge G.W. Jr., Whelan T.J., Pfister D.G. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. Vol. 19 (5). Р. 1539–1569.Recht A., Edge S., Solin L., Robinson D.S., Estabrook A., Fine R.E., Fleming G.F., Formenti S., Hudis C., Kirshner J.J., Krause D.A., Kuske R.R., Langer A.S., Sledge G.W. Jr., Whelan T.J., Pfister D.G. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. Vol. 19 (5). Р. 1539–1569.Schiffman S.C., McMasters K.M., Scoggins C.R., Martin R.C., Chagpar A.B. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients // J. Am. Coll. Surg. 2011. Vol. 213 (1). Р. 45–52. doi: 10.1016/j.jamcollsurg.2011.04.024.83Schiffman S.C., McMasters K.M., Scoggins C.R., Martin R.C., Chagpar A.B. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients // J. Am. Coll. Surg. 2011. Vol. 213 (1). Р. 45–52. doi: 10.1016/j.jamcollsurg.2011.04.024.83Schiffman S.C., McMasters K.M., Scoggins C.R., Martin R.C., Chagpar A.B. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients // J. Am. Coll. Surg. 2011. Vol. 213 (1). Р. 45–52. doi: 10.1016/j.jamcollsurg.2011.04.024.83Schiffman S.C., McMasters K.M., Scoggins C.R., Martin R.C., Chagpar A.B. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients // J. Am. Coll. Surg. 2011. Vol. 213 (1). Р. 45–52. doi: 10.1016/j.jamcollsurg.2011.04.024.83Sheikh F., Rebecca А., Pockaj B., Wasif N., McCullough A.E., Casey W., Kreymerman P., Gray R.J. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk? // Ann. Surg. Oncol. 2011. Vol. 18 (4). Р. 952–956. doi: 10.1245/s10434-010-1406-4.Sheikh F., Rebecca А., Pockaj B., Wasif N., McCullough A.E., Casey W., Kreymerman P., Gray R.J. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk? // Ann. Surg. Oncol. 2011. Vol. 18 (4). Р. 952–956. doi: 10.1245/s10434-010-1406-4.Sheikh F., Rebecca А., Pockaj B., Wasif N., McCullough A.E., Casey W., Kreymerman P., Gray R.J. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk? // Ann. Surg. Oncol. 2011. Vol. 18 (4). Р. 952–956. doi: 10.1245/s10434-010-1406-4.Sheikh F., Rebecca А., Pockaj B., Wasif N., McCullough A.E., Casey W., Kreymerman P., Gray R.J. Inadequate Margins of Excision When Undergoing Mastectomy for Breast Cancer: Which Patients are at Risk? // Ann. Surg. Oncol. 2011. Vol. 18 (4). Р. 952–956. doi: 10.1245/s10434-010-1406-4.Sobin L.H., Greene F.L. Multifocal/multicentric breast carcinoma // Cancer. 2004. Vol. 100 (11). Р. 2488–2489.Sobin L.H., Greene F.L. Multifocal/multicentric breast carcinoma // Cancer. 2004. Vol. 100 (11). Р. 2488–2489.Sobin L.H., Greene F.L. Multifocal/multicentric breast carcinoma // Cancer. 2004. Vol. 100 (11). Р. 2488–2489.Sobin L.H., Greene F.L. Multifocal/multicentric breast carcinoma // Cancer. 2004. Vol. 100 (11). Р. 2488–2489.Stranzl H., Ofner P., Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? // Strahlenther. Onkol. 2006. Vol. 182. Р. 583–588.Stranzl H., Ofner P., Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? // Strahlenther. Onkol. 2006. Vol. 182. Р. 583–588.Stranzl H., Ofner P., Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? // Strahlenther. Onkol. 2006. Vol. 182. Р. 583–588.Stranzl H., Ofner P., Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? // Strahlenther. Onkol. 2006. Vol. 182. Р. 583–588.Taylor M.E., Haffty B.G., Rabinovitch R., Arthur D.W., Halberg F.E., Strom E.A., White J.R., Cobleigh M.A., Edge S.B. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncologybreast // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (4). P. 997–1002. doi: 10.1016/j.ijrobp.2008.10.080.Taylor M.E., Haffty B.G., Rabinovitch R., Arthur D.W., Halberg F.E., Strom E.A., White J.R., Cobleigh M.A., Edge S.B. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncologybreast // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (4). P. 997–1002. doi: 10.1016/j.ijrobp.2008.10.080.Taylor M.E., Haffty B.G., Rabinovitch R., Arthur D.W., Halberg F.E., Strom E.A., White J.R., Cobleigh M.A., Edge S.B. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncologybreast // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (4). P. 997–1002. doi: 10.1016/j.ijrobp.2008.10.080.Taylor M.E., Haffty B.G., Rabinovitch R., Arthur D.W., Halberg F.E., Strom E.A., White J.R., Cobleigh M.A., Edge S.B. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncologybreast // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 73 (4). P. 997–1002. doi: 10.1016/j.ijrobp.2008.10.080.Trovo M., Durofil E., Polesel J., Roncadin M., Perin T., Mileto M., Piccoli E., Quitadamo D., Massarut S., Carbone A., Trovo M.G. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (2). Р. 153–157. doi: 10.1016/j.ijrobp.2011.12.050.Trovo M., Durofil E., Polesel J., Roncadin M., Perin T., Mileto M., Piccoli E., Quitadamo D., Massarut S., Carbone A., Trovo M.G. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (2). Р. 153–157. doi: 10.1016/j.ijrobp.2011.12.050.Trovo M., Durofil E., Polesel J., Roncadin M., Perin T., Mileto M., Piccoli E., Quitadamo D., Massarut S., Carbone A., Trovo M.G. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (2). Р. 153–157. doi: 10.1016/j.ijrobp.2011.12.050.Trovo M., Durofil E., Polesel J., Roncadin M., Perin T., Mileto M., Piccoli E., Quitadamo D., Massarut S., Carbone A., Trovo M.G. Locoregional Failure in Early-Stage Breast Cancer Patients Treated With Radical Mastectomy and Adjuvant Systemic Therapy: Which Patients Benefit From Postmastectomy Irradiation? // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83 (2). Р. 153–157. doi: 10.1016/j.ijrobp.2011.12.050.Truong P.T., Olivotto I.A., Kader H.A., Panades M., Speers C.H., Berthelet E. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61 (5). P. 1337–1347.Truong P.T., Olivotto I.A., Kader H.A., Panades M., Speers C.H., Berthelet E. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61 (5). P. 1337–1347.Truong P.T., Olivotto I.A., Kader H.A., Panades M., Speers C.H., Berthelet E. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61 (5). P. 1337–1347.Truong P.T., Olivotto I.A., Kader H.A., Panades M., Speers C.H., Berthelet E. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 61 (5). P. 1337–1347.Truong P.T., Woodward W.A., Thames H.D., Ragaz J., Olivotto I.A., Buchholz T.A. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (1). P. 59–65.Truong P.T., Woodward W.A., Thames H.D., Ragaz J., Olivotto I.A., Buchholz T.A. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (1). P. 59–65.Truong P.T., Woodward W.A., Thames H.D., Ragaz J., Olivotto I.A., Buchholz T.A. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (1). P. 59–65.Truong P.T., Woodward W.A., Thames H.D., Ragaz J., Olivotto I.A., Buchholz T.A. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68 (1). P. 59–65.Ustaalioglu B.O., Bilici A., Kefeli U., Şeker M., Oncel M., Gezen C., Gumus M., Demirelli F. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancerpatients: single center experience // Am. J. Clin. Oncol. 2012. Vol. 35 (6). Р. 580–586. doi: 10.1097/COC.0b013e31822d9cd6.Ustaalioglu B.O., Bilici A., Kefeli U., Şeker M., Oncel M., Gezen C., Gumus M., Demirelli F. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancerpatients: single center experience // Am. J. Clin. Oncol. 2012. Vol. 35 (6). Р. 580–586. doi: 10.1097/COC.0b013e31822d9cd6.Ustaalioglu B.O., Bilici A., Kefeli U., Şeker M., Oncel M., Gezen C., Gumus M., Demirelli F. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancerpatients: single center experience // Am. J. Clin. Oncol. 2012. Vol. 35 (6). Р. 580–586. doi: 10.1097/COC.0b013e31822d9cd6.Ustaalioglu B.O., Bilici A., Kefeli U., Şeker M., Oncel M., Gezen C., Gumus M., Demirelli F. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancerpatients: single center experience // Am. J. Clin. Oncol. 2012. Vol. 35 (6). Р. 580–586. doi: 10.1097/COC.0b013e31822d9cd6.Wallgren A., Bonetti M., Gelber R., Goldhirsch A., CastiglioneGertsch M., Holmberg S.B., Lindtner J., Thürlimann B., Fey M., Werner I.D., Forbes J.F., Price K., Coates A.S., Collins J. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII // J. Clin. Oncol. 2003. Vol. 21 (7). Р. 1205–1213.Wallgren A., Bonetti M., Gelber R., Goldhirsch A., CastiglioneGertsch M., Holmberg S.B., Lindtner J., Thürlimann B., Fey M., Werner I.D., Forbes J.F., Price K., Coates A.S., Collins J. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII // J. Clin. Oncol. 2003. Vol. 21 (7). Р. 1205–1213.Wallgren A., Bonetti M., Gelber R., Goldhirsch A., CastiglioneGertsch M., Holmberg S.B., Lindtner J., Thürlimann B., Fey M., Werner I.D., Forbes J.F., Price K., Coates A.S., Collins J. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII // J. Clin. Oncol. 2003. Vol. 21 (7). Р. 1205–1213.Wallgren A., Bonetti M., Gelber R., Goldhirsch A., CastiglioneGertsch M., Holmberg S.B., Lindtner J., Thürlimann B., Fey M., Werner I.D., Forbes J.F., Price K., Coates A.S., Collins J. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII // J. Clin. Oncol. 2003. Vol. 21 (7). Р. 1205–1213.Yang P.S., Chen C.M., Liu M.C., Jian J.M., Horng C.F., Liu M.J., Yu B.L., Lee M.Y., Chi C.W. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77 (2). Р. 516–522. doi: 10.1016/j.ijrobp.2009.05.016.Yang P.S., Chen C.M., Liu M.C., Jian J.M., Horng C.F., Liu M.J., Yu B.L., Lee M.Y., Chi C.W. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77 (2). Р. 516–522. doi: 10.1016/j.ijrobp.2009.05.016.Yang P.S., Chen C.M., Liu M.C., Jian J.M., Horng C.F., Liu M.J., Yu B.L., Lee M.Y., Chi C.W. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77 (2). Р. 516–522. doi: 10.1016/j.ijrobp.2009.05.016.Yang P.S., Chen C.M., Liu M.C., Jian J.M., Horng C.F., Liu M.J., Yu B.L., Lee M.Y., Chi C.W. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 77 (2). Р. 516–522. doi: 10.1016/j.ijrobp.2009.05.016.

The authors declare that there are no conflicts of interest present.